TFF Pharmaceuticals | 8-K:TFF Pharmicals公布第二季度财务业绩并提供公司最新情况
TFF Pharmaceuticals | 10-Q:季度报表
TFF Pharmaceuticals | 8-K:重大事件
TFF Pharmaceuticals | 4:持股变动声明-高管 Weisman Harlan F
TFF Pharmaceuticals | 4:持股变动声明-董事 Lee Catherine Chai-zon
TFF Pharmaceuticals | 4:持股变动声明-董事 MILLS ROBERT S
TFF Pharmaceuticals | 4:持股变动声明-董事 Roberts Brandi
TFF Pharmaceuticals | 4:持股变动声明-高管 COLEMAN KIRK ALLEN
TFF Pharmaceuticals | 4:持股变动声明-高管 Mikhak Zamaneh
TFF Pharmaceuticals | 4:持股变动声明-董事 ROCAMBOLI STEPHEN
TFF Pharmaceuticals | 4:持股变动声明-董事 KING THOMAS BRAXTON
TFF Pharmaceuticals | 8-K:重大事件
TFF Pharmaceuticals | S-8:员工福利计划证券登记
TFF Pharmaceuticals | 8-K:重大事件
TFF Pharmaceuticals | 8-K:重大事件
TFF Pharmaceuticals | 424B5:募资说明书
TFF Pharmaceuticals | 8-K:TFF Pharmicals公布第一季度财务业绩并提供公司最新情况
TFF Pharmaceuticals | 10-Q:2024财年一季报
TFF Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%)等
TFF Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Double Black Diamond Offshore Ltd.(9.12%),Carlson Capital, L.P.(9.12%)等
暂无数据